MDAI is an analogue of MDA aka MDMA, is a psychoactive research chemical that has stimulant properties. MDAI (also known as 5,6-Methylenedioxy-2-aminoindane) was developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans. Cas No: 132741-81-2 Formula: C10H11NO2 IUPAC: Appearance: Purity: